Profile data is unavailable for this security.
About the company
Zhejiang Shouxiangu Pharmaceutical Co Ltd is a China-based company principally engaged in the breeding, cultivation, processing and sales of traditional Chinese medicinal materials, such as the ganoderma lucidums and dendrobium officinales. The Company's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The Company mainly operates its businesses in domestic markets through wholesaling and direct sales.
- Revenue in CNY (TTM)765.44m
- Net income in CNY265.12m
- Incorporated1997
- Employees1.14k
- LocationZhejiang Shouxiangu Pharmaceutical Co LtdNo. 12 Huanglong 3rd Road, Wuyi CountyJINHUA 321200ChinaCHN
- Phone+86 57 987622285
- Fax+86 57 987621769
- Websitehttp://www.sxg1909.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai New World Co Ltd | 1.14bn | 40.16m | 4.22bn | 1.20k | 105.20 | 1.00 | -- | 3.70 | 0.0621 | 0.0621 | 1.77 | 6.53 | 0.2015 | 4.35 | 14.44 | 949,188.30 | 0.6934 | 0.5242 | 0.9222 | 0.7249 | 38.93 | 33.70 | 3.44 | 2.71 | 1.54 | -- | 0.1374 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
Yabao Pharmaceutical Group Co Ltd | 2.82bn | 211.33m | 4.26bn | 4.14k | 20.51 | 1.48 | -- | 1.51 | 0.2886 | 0.2886 | 3.78 | 3.99 | 0.7255 | 3.17 | 6.31 | 680,979.10 | 4.85 | 2.82 | 6.22 | 3.97 | 55.14 | 59.20 | 6.68 | 4.19 | 1.64 | 75.03 | 0.0779 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
Pulike Biological Engineering Inc | 1.12bn | 130.97m | 4.29bn | 1.68k | 33.13 | 1.62 | -- | 3.83 | 0.3743 | 0.3743 | 3.18 | 7.65 | 0.3485 | 2.33 | 2.66 | 667,816.40 | 4.07 | 7.64 | 4.77 | 8.96 | 60.15 | 62.57 | 11.68 | 17.85 | 2.26 | -- | 0.0127 | 52.48 | 1.84 | 15.55 | 3.99 | 5.17 | 41.58 | 18.47 |
Shanghai Hile Bio-Technology Co Ltd | 220.43m | 33.32m | 4.32bn | 295.00 | 137.79 | 3.37 | -- | 19.61 | 0.0477 | 0.0477 | 0.3333 | 1.95 | 0.1358 | 1.12 | 2.36 | 747,217.40 | 1.33 | 1.73 | 1.67 | 2.47 | 43.60 | 50.44 | 9.83 | 10.37 | 1.13 | -- | 0.174 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
Zhejiang Shouxiangu Pharmaceuticl Co Ltd | 765.44m | 265.12m | 4.41bn | 1.14k | 16.45 | 2.03 | -- | 5.77 | 1.35 | 1.35 | 3.89 | 10.94 | 0.2496 | 0.7366 | 8.34 | 669,678.30 | 8.65 | 10.04 | 10.50 | 11.63 | 81.12 | 83.66 | 34.64 | 28.29 | 3.25 | -- | 0.2226 | 47.86 | -5.39 | 8.93 | -8.39 | 18.78 | 12.23 | 17.13 |
ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.81bn | 321.42m | 4.53bn | 5.34k | 14.22 | 1.89 | -- | 1.19 | 0.7513 | 0.7513 | 8.87 | 5.64 | 0.8606 | 3.70 | 9.48 | 714,144.30 | 9.03 | 8.99 | 16.81 | 16.21 | 45.17 | 44.59 | 10.49 | 10.03 | 2.01 | -- | 0.1552 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
Jinyao Pharmaceutical Co Ltd | 3.56bn | 135.67m | 4.54bn | 2.68k | 33.47 | 1.51 | -- | 1.28 | 0.124 | 0.124 | 3.26 | 2.75 | 0.5643 | 2.27 | 7.69 | 1,329,556.00 | 2.93 | 1.91 | 5.06 | 3.40 | 42.62 | 46.33 | 5.19 | 3.31 | 0.8002 | 16.12 | 0.2205 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
Jiangsu Jibeier Pharmaceutical Co Ltd | 875.78m | 244.83m | 4.65bn | 1.45k | 17.88 | 2.11 | -- | 5.31 | 1.31 | 1.31 | 4.67 | 11.04 | 0.3872 | 3.32 | 3.55 | 606,078.30 | 10.81 | 9.77 | 11.94 | 10.66 | 87.91 | 88.44 | 27.92 | 23.29 | 6.04 | -- | 0.0061 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
Data as of Oct 11 2024. Currency figures normalised to Zhejiang Shouxiangu Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 14.56m | 7.38% |
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 6.34m | 3.22% |
Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 4.69m | 2.38% |
Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 4.51m | 2.29% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.10m | 0.56% |
Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 878.00k | 0.45% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 799.38k | 0.41% |
Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 521.80k | 0.27% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 327.28k | 0.17% |
CCB Principal Asset Management Co., Ltd.as of 31 Dec 2023 | 289.06k | 0.15% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.